Clinical Trial Update: Rituximab in Patients With Acute Rheumatic Fever [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab for acute rheumatic fever and rheumatic heart disease in children has been suspended with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Fever
• Rheumatic Heart Disease

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: African Academy of Methodology and Statistics | Conditions: Rheumatic Heart Disease in Children | Phase 2 | Status: SUSPENDED